Back to jobs
Gilead10K+ employees

Director, Clinical Development (MD)

CA$261,375 – $338,250Posted 2 days ago

Immigration summary

Visa sponsorship

LikelyHigh confidence

This employer has recently sponsored work like this.

215 recent H-1B filings · 2 similar-role filings

View visa evidence

Green card sponsorship

Strong historyMedium confidence

This employer has recently sponsored green cards at scale.

59 recent certified PERM filings

View green card evidence

Job description

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description

Key Responsibilities

  • Provide clinical and scientific leadership for one or more inflammation development programs.
  • Develop and continually refine the Clinical Development Plan (CDP), including indication strategy, target populations, clinical sequencing, success criteria, and key development decisions.
  • Lead the design and execution of early- and mid-stage clinical trials, including Phase 1b/2 proof-of-concept and dose-ranging studies.
  • Translate complex immunology and human disease biology into testable clinical hypotheses and development strategy.
  • Integrate clinical, translational, biomarker, pharmacologic, and competitive data to inform asset strategy and decision-making.
  • Provide medical leadership for protocols, eligibility criteria, endpoints, safety monitoring, dose selection, and benefit-risk assessment.
  • Partner closely and proactively with Clinical Operations, Biostatistics, Clinical Pharmacology, Translational Medicine, Research, Regulatory Affairs, Safety, Medical Affairs, and Commercial colleagues.
  • Represent Clinical Development on cross-functional asset teams and contribute to governance presentations and development recommendations.
  • Build and share institutional knowledge across the portfolio, contributing expertise beyond a single asset so that learnings, assumptions, and strategy are aligned across programs rather than siloed.
  • Develop productive relationships with investigators, external scientific experts, and key opinion leaders.
  • Contribute to regulatory strategy and health authority interactions, including preparation and review of clinical sections of regulatory documents.

Qualifications

Required

  • MD, PhD, or equivalent advanced degree, with 6+ years of relevant experience in biopharmaceutical clinical development or academic clinical research.
  • Demonstrated expertise in immunology, inflammation, or immune-mediated disease.
  • Significant experience in biopharmaceutical clinical development and/or highly relevant academic clinical investigation.
  • Experience designing, conducting, and interpreting interventional clinical trials.
  • Strong command of trial design, endpoints, statistics, safety assessment, and drug development principles.
  • Ability to critically evaluate emerging biological and clinical data and convert it into clear development decisions.
  • Demonstrated success working through multidisciplinary teams and influencing without direct authority.
  • Strong written and verbal communication skills, including translating complex science for non-specialist audiences.
  • Comfort operating in a rapidly evolving environment where strategic and scientific questions remain open.

Preferred

  • Clinical or development expertise in pulmonary/respiratory medicine or dermatology, ideally asthma, COPD, atopic dermatitis, hidradenitis suppurativa, or related inflammatory disease.
  • Board certification or advanced training in pulmonary medicine, allergy/immunology, dermatology, rheumatology, or a related specialty.
  • Experience developing small molecules and/or novel targeted modalities in immune-mediated disease.
  • Experience spanning first-in-human through proof-of-concept and Phase 2, including dose selection and evidence-generation strategy.
  • Experience developing and applying pharmacodynamic, translational, or patient-selection biomarkers.
  • Experience contributing to INDs and FDA or global regulatory interactions.

The salary range for this position is: $261,375.00 - $338,250.00. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

For additional benefits information, visit:

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

For jobs in the United States:

Gilead Sciences Inc. is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact ApplicantAccommodations@gilead.com for assistance.

For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

Gilead Sciences will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the  legal duty to furnish information; or (d) otherwise protected by law.

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please apply via the Internal Career Opportunities portal in Workday.

Sponsorship evidence

Why Openbound reached the conclusions above.

Visa sponsorship evidence

Current posting

Silent on sponsorship

Employer H-1B history

215
recent certified H-1B filings
132
new-hire petitions
2
filings for similar roles
169
so far in FY2026

Filed titles like this role: director clinical development md · assoc clinical development director md

More evidence details
  • 2 certified H-1B filings for this same role
  • 215 recent certified H-1B filings across the employer
  • Still filing this year — 169 filings in FY2026
  • 45 USCIS H-1B new-employment approvals, counted separately from LCA filings
  • Strong filing activity in CA
  • 383 further USCIS approvals for extensions or transfers
  • The posting says nothing about sponsorship either way

Strong filing activity in CA.

Green card sponsorship evidence

Employer PERM history

59
recent certified PERM filings
0
filings for similar roles
42
filings in this location
Certified PERM filings by fiscal year
202356
202445
202569
202665YTD

Filing history reflects past employer behavior; it isn't a promise for this opening.

All open roles at Gilead
How Openbound evaluates sponsorship

Visa history uses official U.S. Department of Labor H-1B LCA disclosure data and USCIS H-1B petition history. Green card history uses DOL PERM disclosure data. Each is read for the employer as a whole, for roles like this one, and for this location, weighted toward the most recent fiscal years.

An employer is matched to its filing entities by verified legal name and reviewed aliases; a match is never made on a name resemblance alone. Where no verified entity can be matched, the page says so and draws no conclusion from the absence. 271 filing titles were examined for this employer.

What this posting states outranks history in both directions, and an employer's published policy outranks past filings. Filing history reflects past behavior; it is not a promise of sponsorship for this opening, and none of this is legal advice.